Literature DB >> 23807042

Relationship between hepcidin and ferritin in haemodialysed patients.

Terezie Sedlackova1, Jaroslav Racek, Daniel Rajdl, Lukas Kielberger, Jaromir Eiselt, Lada Malanova, Vaclav Babuska.   

Abstract

BACKGROUND: Hepcidin is a key regulator of iron metabolism. It binds to ferroportin and causes the trapping of iron in cells, rendering it unavailable for erythropoiesis. The synthesis of hepcidin is upregulated by high iron stores and inflammation. Haemodialysed patients suffer from anaemia and impaired iron management, the cause of which is multifactorial. Our aim was to describe the relationship between hepcidin and other parameters of iron metabolism, erythropoiesis, and inflammation. PATIENTS,
MATERIALS AND METHODS: Complete blood cell counts, hepcidin, parameters of iron metabolism, and inflammation were measured in samples from 164 dialysed patients and 37 control healthy volunteers. Patients were subdivided according to the time of dialysis session.
RESULTS: According to the time of haemodialysis, iron levels showed an insignificant tendency for diurnal variability, whereas hepcidin levels were markedly different. Non-parametric correlations showed a weak, but statistically significant correlation between parameters of iron metabolism and inflammation in the entire group of patients. No correlation was found between hepcidin and other biochemical parameters in controls. Non-parametric correlations were also performed in the time subgroups of patients.
CONCLUSION: It seems that the influence of inflammation on hepcidin levels in haemodialysed patients is not crucial and other factors (e.g. hepcidin retention) are involved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23807042     DOI: 10.1007/s00508-013-0388-1

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  21 in total

1.  Variation of serum iron concentration in young healthy men: Within-day and day-to-day changes.

Authors:  B E Statland; P Winkel; H Bokelund
Journal:  Clin Biochem       Date:  1976-02       Impact factor: 3.281

2.  Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System.

Authors:  Naohisa Tomosugi; Hiroshi Kawabata; Rumi Wakatabe; Masato Higuchi; Hideki Yamaya; Hisanori Umehara; Isao Ishikawa
Journal:  Blood       Date:  2006-04-18       Impact factor: 22.113

3.  Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications.

Authors:  Erwin H J M Kemna; Harold Tjalsma; Vladimir N Podust; Dorine W Swinkels
Journal:  Clin Chem       Date:  2007-02-01       Impact factor: 8.327

4.  Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice.

Authors:  Soichiro Tajima; Yasumasa Ikeda; Kaori Sawada; Noriko Yamano; Yuya Horinouchi; Yoshitaka Kihira; Keisuke Ishizawa; Yuki Izawa-Ishizawa; Kazuyoshi Kawazoe; Shuhei Tomita; Kazuo Minakuchi; Koichiro Tsuchiya; Toshiaki Tamaki
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-09-13       Impact factor: 4.310

5.  Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation.

Authors:  Takahiro Kuragano; Yasushi Shimonaka; Aritoshi Kida; Minoru Furuta; Masayoshi Nanami; Yoshinaga Otaki; Yukiko Hasuike; Hiroshi Nonoguchi; Takeshi Nakanishi
Journal:  Am J Nephrol       Date:  2010-05-14       Impact factor: 3.754

6.  Diurnal and nocturnal variations of the serum iron in normal subjects.

Authors:  W F Wiltink; J Kruithof; C Mol; M G Bos; H G van Eijk
Journal:  Clin Chim Acta       Date:  1973-11-23       Impact factor: 3.786

7.  Serum hepcidin in haemodialysis patients: associations with iron status and microinflammation.

Authors:  Y Xu; X Q Ding; J Z Zou; Z H Liu; S H Jiang; Y M Chen
Journal:  J Int Med Res       Date:  2011       Impact factor: 1.671

Review 8.  Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation.

Authors:  Tomas Ganz
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

9.  Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease.

Authors:  Damien R Ashby; Daniel P Gale; Mark Busbridge; Kevin G Murphy; Neill D Duncan; Tom D Cairns; David H Taube; Stephen R Bloom; Frederick W K Tam; Richard S Chapman; Patrick H Maxwell; Peter Choi
Journal:  Kidney Int       Date:  2009-02-11       Impact factor: 10.612

Review 10.  Circadian sleep-wake rhythm disturbances in end-stage renal disease.

Authors:  Birgit C P Koch; J Elsbeth Nagtegaal; Gerard A Kerkhof; Piet M ter Wee
Journal:  Nat Rev Nephrol       Date:  2009-05-26       Impact factor: 28.314

View more
  2 in total

1.  Quantitative measurement of brain iron deposition in patients with haemodialysis using susceptibility mapping.

Authors:  Chao Chai; Shuo Yan; Zhiqiang Chu; Tong Wang; Lijun Wang; Mengjie Zhang; Chao Zuo; E Mark Haacke; Shuang Xia; Wen Shen
Journal:  Metab Brain Dis       Date:  2014-09-03       Impact factor: 3.584

2.  Iron Profile and Inflammatory Status of Overweight and Obese Women in Sari, North of Iran.

Authors:  Ramin Shekarriz; Mohammad Mehdi Vaziri
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.